The foundation invested in CureVac to accelerate vaccine technology development, getting life-saving and low-cost vaccines to people who need them most. CureVac is pioneering the use of natural and chemically unmodified mRNA-based vaccine technologies to fight diseases that disproportionately impact people in developing countries.
Investment Date: January 2015